A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
about
Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.Platelet function testing in cardiac surgery.Antithrombotic therapy for patients with STEMI undergoing primary PCI.Ticagrelor - toward more efficient platelet inhibition and beyond.Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease.Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study.
P2860
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A head-to-head pharmacodynamic ...... prospective randomized study.
@en
type
label
A head-to-head pharmacodynamic ...... prospective randomized study.
@en
prefLabel
A head-to-head pharmacodynamic ...... prospective randomized study.
@en
P2093
P2860
P356
P1476
A head-to-head pharmacodynamic ...... prospective randomized study.
@en
P2093
Ana Muniz-Lozano
Christopher DeGroat
Dominick J Angiolillo
Elisabetta Ferrante
Elizabeth C Dunn
Fabiana Rollini
Francesco Franchi
Jung Rae Cho
Kamaldeep Singh
Luis A Guzman
P2860
P304
P356
10.1093/EURHEARTJ/EHV744
P577
2016-02-03T00:00:00Z